From Nasdaq: 2025-05-07 01:19:00

Fresenius SE reported higher adjusted profit in Q1, excluding Fresenius Medical Care, with an increase in revenues. Adjusted net income was 416 million euros, up from 371 million euros last year, and earnings per share were 0.74 euro. Group adjusted EBIT was 654 million euros, a 4% increase, while group revenue grew 7% to 5.63 billion euros. For fiscal 2025, Fresenius expects organic revenue growth of 4-6% and constant currency EBIT growth of 3-7%. In fiscal 2024, revenues were 21.53 billion euros and EBIT was 2.49 billion euros. Fresenius Kabi and Helios are expected to see continued growth.



Read more at Nasdaq: Fresenius Q1 Adj. Earnings Rise, Margin Down; Confirms FY25 Outlook